6 Dimensions' immuno-oncology play Curon raises $150M series A

Curon Biopharmaceutical (Shanghai, China) raised $150 million in a series A round from 6 Dimensions Capital, Boyu Capital and Temasek.

Curon will use the funds to expand its pipeline of next-generation immunotherapeutic cancer agents. 6 Dimensions, which incubated the biotech, did not respond to inquiries regarding the financing round or Curon's pipeline...